Home Products Microsatellite Instability Testing Promega has been a leader in Microsatellite Instability (MSI) research for over 15 years. With precision performance and expert support, the Promega MSI Analysis System is the gold standard MSI assay in clinical research. MSI testing of tumor tissue has been routinely performed by Polymerase Chain Reaction (PCR) and Capillary Electrophoresis (CE) resolution for many years with the goal of identifying functional evidence of genomic instability (loss of DNA mismatch repair system) associated with research in hereditary cancers called Lynch Syndrome. Recently, the role of MSI as a biomarker has been expanded past its classical association with Lynch Syndrome, to also becoming a solid tumor, tissue agnostic marker for patient selection for cancer immunotherapeutics called immune checkpoint inhibitors. We provide microsatellite instability testing products for research use globally, and for IVD use in certain countries. Learn how the OncoMate™ MSI Dx Analysis System determines MSI status of tumor samples, offering actionable results can be used to inform testing and treatment options. Learn about MSI Shop MSI Products What is Microsatellite Instability (MSI)? Microsatellite Instability is the accumulation of insertion or deletion errors at microsatellite repeat sequences in cancerous cells as a result of a deficiency within one or more major DNA mismatch repair proteins (dMMR). Microsatellite instability testing (MSI testing) measures the ability of a cell to repair mistakes in DNA replication. Every time a cell divides, the DNA of that cell is copied. The machinery of the cell sometimes makes mistakes when copying the DNA before cell division. One of these errors is called mismatch, when extra nucleotides are inserted into or deleted from the newly synthesized strand of DNA and there are no corresponding matches on the template strand. Normal cells have a system, called mismatch repair (MMR), to detect and correct such errors. Certain parts of the genome called microsatellites are particularly sensitive to mismatch errors and serve as markers of mismatch repair deficiency (dMMR). Mononucleotide repeat microsatellite sequences found throughout the genome are particularly sensitive to transcription errors. Thus, high frequency microsatellite instability (MSI-H) is considered a marker for the presence of mutations in, or methylation silencing of, certain major DNA MMR genes. Recently, MSI status has been rediscovered as a biomarker for immunotherapeutic response, making MSI status an increasingly relevant tool in genetic- and immuno-oncology research. MSI analysis typically involves comparing allelic profiles of microsatellite markers generated by amplification from matching pairs of test and normal tissue samples. Changes in the amplification fragment size in the test sample compared to the corresponding normal sample are indicative of MSI. Promega produced the first commercially available kit for researching MSI in 2004. Microsatellite Instability Testing Product Groups Clinical MSI Testing Precision MSI analysis systems for in vitro diagnostic use. MSI Analysis for Research MSI analysis for the clinical research laboratory. Top Microsatellite Instability Testing Products for Your Lab MSI Analysis System, Version 1.2 PCR-based method for detecting microsatellite instability (MSI) in research samples. MD1641 Internal Lane Standard 600 Consists of 22 bands ranging from 60bp to 600bp. DG1071 OncoMate™ MSI Dx Analysis System IVD Medical Device for MSI testing of solid tumors. PCR-based fragment-sizing test used to determine microsatellite instability (MSI) status. MD3140 Microsatellite Instability Testing Resources Resource The Evolution of MSI Detection Webinar Past, Present and Future Advances in MSI Testing Resource Microsatellite Instability Resource Center Let's find the product that meets your needs. Talk to a Scientist Uwe Germany Don't miss out! Stay notified of Promega events, products and news. Sign Up Need Assistance? Contact Promega Customer and Technical Support Local Contact +31 (0)71 532 42 44 Products & Resources Products Applications Custom Capabilities Resources About Promega Company Info ISO Certification Corporate Responsibility Press Releases Careers © 2021 Promega Corporation, an affiliate of Promega Benelux BV. All rights reserved. Legal and Trademarks Privacy Policy Terms and Conditions Trademarks Promotional Terms and Conditions Terms and Conditions of Sale and Services Manage Cookie Consent English – Belgium Promega's Cookie Policy Close We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy. If you are located in the EEA , the United Kingdom, or Switzerland, you can change your settings at any time by clicking Manage Cookie Consent in the footer of our website. Manage My Cookies Reject All Cookies Yes, I Accept